美国住院成瘾治疗计划提供的疗法。
Therapies Offered at Residential Addiction Treatment Programs in the United States.
机构信息
Department of Health Policy and Management, Yale University, New Haven, Connecticut.
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
出版信息
JAMA. 2020 Aug 25;324(8):804-806. doi: 10.1001/jama.2020.8969.
Abstract
This study uses simulated patient calls to a random sample of US residential addiction treatment facilities to investigate the availability of opioid agonist treatment (buprenorphine-naloxone) and nonpharmacologic therapies (eg, CBT) for opioid use disorder, and differences by for-profit vs nonprofit center status.
摘要
本研究采用模拟患者致电美国随机抽样的住院成瘾治疗机构，以调查阿片类药物使用障碍的阿片类激动剂治疗（丁丙诺啡-纳洛酮）和非药物治疗（如 CBT）的可及性，以及营利性和非营利性中心地位的差异。
相似文献
1
Therapies Offered at Residential Addiction Treatment Programs in the United States.美国住院成瘾治疗计划提供的疗法。
JAMA. 2020 Aug 25;324(8):804-806. doi: 10.1001/jama.2020.8969.
2
The Promises And Pitfalls Of Treating Addiction.治疗成瘾的承诺与陷阱。
Health Aff (Millwood). 2017 Dec;36(12):2204-2206. doi: 10.1377/hlthaff.2017.0632.
3
Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.阿片类药物成瘾的药物辅助康复：历史和当代视角。
J Addict Dis. 2012;31(3):199-206. doi: 10.1080/10550887.2012.694597.
4
Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.慢性疼痛患者的疼痛波动性与处方阿片类药物成瘾治疗结果
Exp Clin Psychopharmacol. 2015 Dec;23(6):428-35. doi: 10.1037/pha0000039. Epub 2015 Aug 24.
5
Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.国家药物滥用治疗临床试验网络处方阿片类药物成瘾治疗研究的长期结果。
Drug Alcohol Depend. 2015 May 1;150:112-9. doi: 10.1016/j.drugalcdep.2015.02.030. Epub 2015 Mar 6.
6
US needs $1.1bn to treat opioid addiction.美国需要11亿美元来治疗阿片类药物成瘾问题。
BMJ. 2016 Feb 5;352:i694. doi: 10.1136/bmj.i694.
7
Outpatient opioid addiction treatment using buprenorphine.使用丁丙诺啡的门诊阿片类药物成瘾治疗。
Ala Nurse. 2010 Jun-Aug;37(2):13-6; quiz 17.
8
Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough?消除阿片类药物使用障碍治疗的一个障碍：这足够了吗？
JAMA. 2021 Mar 23;325(12):1147-1148. doi: 10.1001/jama.2021.0958.
9
Managing addiction to prescribed opioids: the job of general practice?应对处方阿片类药物成瘾：这是全科医疗的工作吗？
Br J Gen Pract. 2018 Sep;68(674):426-427. doi: 10.3399/bjgp18X698597.
10
A (In)curable Disease? Making Meaning of Addiction from the Perspective of People in Recovery from Opioid Use Disorder.一种（无法）治愈的疾病？从阿片类药物使用障碍康复者的角度理解成瘾。
Health Commun. 2023 Dec;38(13):2936-2944. doi: 10.1080/10410236.2022.2128157. Epub 2022 Sep 30.
引用本文的文献
1
Nonabstinence among US Adults in Recovery from an Alcohol or Other Drug Problem.美国从酒精或其他药物问题中恢复的成年人中的非戒酒情况。
J Addict Med. 2024 Nov 15. doi: 10.1097/ADM.0000000000001408.
2
Hospital Provider's Perspectives on MOUD Initiation and Continuation After Inpatient Discharge.医院提供者对住院出院后启动和持续使用药物辅助治疗的看法。
J Gen Intern Med. 2024 Nov 25. doi: 10.1007/s11606-024-09008-x.
3
Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample.探索阿片类物质使用障碍治疗药物的生活体验：一项众包便利样本的定性研究
Community Ment Health J. 2025 Apr;61(3):411-419. doi: 10.1007/s10597-024-01345-9. Epub 2024 Sep 5.
4
Evidence-based treatment for opioid use disorder is widely unavailable and often discouraged by providers of residential substance use services in North Carolina.北卡罗来纳州的住宅药物使用服务提供者广泛缺乏、且经常不鼓励使用基于证据的阿片类药物使用障碍治疗方法。
J Subst Use Addict Treat. 2024 Dec;167:209474. doi: 10.1016/j.josat.2024.209474. Epub 2024 Aug 22.
5
Telehealth Availability for Mental Health Care During and After the COVID-19 Public Health Emergency.远程医疗在新冠疫情公共卫生紧急事件期间和之后的心理健康护理中的可用性。
JAMA Netw Open. 2024 Jul 1;7(7):e2420853. doi: 10.1001/jamanetworkopen.2024.20853.
6
Major Gaps in the Cascade of Care for Opioid Use Disorder: Implications for Clinical Practice.阿片类物质使用障碍照护流程中的重大差距：对临床实践的启示
JAMA. 2024 Sep 3;332(9):701-702. doi: 10.1001/jama.2024.11977.
7
Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application.支付相关的阿片类药物使用障碍治疗障碍：文献综述及真实世界应用的批判性评价。
J Subst Use Addict Treat. 2024 Oct;165:209441. doi: 10.1016/j.josat.2024.209441. Epub 2024 Jun 19.
8
Adolescent Residential Addiction Treatment In The US: Uneven Access, Waitlists, And High Costs.美国青少年住院成瘾治疗：机会不均等、候补名单和高成本。
Health Aff (Millwood). 2024 Jan;43(1):64-71. doi: 10.1377/hlthaff.2023.00777.
9
Media framings of the role of genomics in "addiction" in the United States from 2015 to 2019: Individualized risk, biomedical expertise, and the limits of destigmatization.2015 年至 2019 年美国媒体对基因组学在“成瘾”中的作用的描述：个体化风险、生物医学专业知识和去污名化的局限性。
Public Underst Sci. 2024 Feb;33(2):158-173. doi: 10.1177/09636625231190743. Epub 2023 Sep 2.
10
Key person-centered care domains for residential substance use disorder treatment facilities: former clients' perspectives.住宅物质使用障碍治疗设施的关键以人为中心的护理领域：前客户的观点。
Subst Abuse Treat Prev Policy. 2023 Jul 17;18(1):45. doi: 10.1186/s13011-023-00554-x.
本文引用的文献
1
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.不同阿片类药物使用障碍治疗途径的疗效比较。
JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622.
2
Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.基于初级保健的丁丙诺啡递减疗法与维持治疗用于处方类阿片类药物依赖：一项随机临床试验。
JAMA Intern Med. 2014 Dec;174(12):1947-54. doi: 10.1001/jamainternmed.2014.5302.
Zotero 插件